This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...